Complex Generic Formulations: Why Proving Bioequivalence Is So Hard
Proving bioequivalence for complex generics - like inhalers, creams, and injectables - is far harder than for simple pills. Learn why these drugs face higher failure rates, regulatory hurdles, and scientific barriers - and what’s being done to bring them to market.